Business
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Resul...
About this update from Oncolytics Biotech Inc.
[{"type":"text","content":"\n \n \n \n Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:1pt; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n.prntal{\nTEXT-ALIGN: LEFT\n}\n \n \n \n \n \n \n Conference call and webcast to take place on Friday, November 5, 2021, at 8:00 a.m. ET\n \n \n PR Newswire\n \n \n \n \n \n SAN DIEGO\n \n and\n \n CALGARY, AB\n \n ,\n \n Oct. 19, 2021\n \n /PRNewswire/ -- Oncolytics Biotech\n \n ®\n \n Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on\n \n Friday, November 5, 2021\n \n , at\n \n 8:00 a.m. ET\n \n to discuss a corporate update and financial results for the third quarter of 2021.\n \n \n \n \n Conference Call & Webcast\n \n \n \n \n \n Date:\n \n Friday, November 5, 2021\n \n \n Time:\n \n 8:00 a.m. Eastern Daylight Time\n \n \n Dial In – North American Toll-Free:\n \n (888) 664-6383\n \n \n Dial In – International:\n \n (416) 764-8650\n \n \n Conference ID\n \n (if needed)\n \n :\n \n 7285-9440\n \n \n Webcast:\n \n please\n \n click here\n \n \n \n A webcast of the call will also be available on the Investor Relations page of Oncolytics' website, available by clicking\n \n here\n \n , and will be archived for three months. A dial in replay will be available for one week and can be accessed by dialing (888) 390-0541 (\n \n North America\n \n ) or (416) 764-8677 (International) and using replay code: 859-440#.\n \n \n \n About Oncolytics Biotech Inc.\n \n \n \n Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype -- turning \"cold\" tumors \"hot\" -- through innate and adaptive immune responses to treat a variety of cancer...